Literature DB >> 19789398

Regional abnormalities of myocardial deformation in patients with hypertrophic cardiomyopathy: correlations with delayed enhancement in cardiac magnetic resonance.

Stefano Ghio1, Miriam Revera, Francesca Mori, Catherine Klersy, Arturo Raisaro, Claudia Raineri, Alessandra Serio, Michele Pasotti, Luigi Oltrona Visconti.   

Abstract

AIMS: Hypertrophic cardiomyopathy (HCM) is a genetic disease histologically characterized by a profound disarray of myocardial fibres and by local fibrosis. We sought to characterize regional left ventricular contractility in HCM patients using deformation analysis and to compare it with the presence or absence of delayed enhancement in cardiac magnetic resonance (CMR). METHODS AND
RESULTS: We studied 58 HCM patients (mean age 41 years, 37 male). The control population comprised 15 normal subjects. Colour tissue-Doppler imaging was acquired in two-dimensional mode from apical four-chamber and two-chamber views; off-line analysis was performed in four basal and four middle left ventricular segments. Gadolinium-enhanced CMR was performed in 36 HCM patients. In HCM patients, peak systolic strain was not uniform across left ventricular segments; differences were not related to site or thickness of the segment analysed. Paradoxically, positive systolic strain values were measured in six middle segments. Delayed CMR enhancement was associated with lower peak systolic strain (P = 0.007). Regional non-uniformities in peak systolic strain were not observed in normal subjects.
CONCLUSION: Areas of reduced left ventricular contractility in deformation analysis are associated with delayed CMR enhancement in patients with HCM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789398     DOI: 10.1093/eurjhf/hfp122

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  10 in total

Review 1.  The genetics of dilated cardiomyopathy.

Authors:  Lisa Dellefave; Elizabeth M McNally
Journal:  Curr Opin Cardiol       Date:  2010-05       Impact factor: 2.161

2.  Subclinical Myocardial Disease in Heart Failure Detected by CMR.

Authors:  Yoshiaki Ohyama; Gustavo J Volpe; Joao A C Lima
Journal:  Curr Cardiovasc Imaging Rep       Date:  2014-04

3.  Cardiac magnetic resonance imaging as a prognostic tool in patients with nonischemic cardiomyopathy.

Authors:  Sara L Partington; Luciana F Seabra; Raymond Y Kwong
Journal:  Hosp Pract (1995)       Date:  2010-11

Review 4.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 5.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

Review 6.  Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment.

Authors:  Efstathios D Pagourelias; Georgios M Alexandridis; Vassilios P Vassilikos
Journal:  Heart Fail Rev       Date:  2021-05-15       Impact factor: 4.214

7.  Systolic Strain Abnormalities to Predict Hospital Readmission in Patients With Heart Failure and Normal Ejection Fraction.

Authors:  Steven M Borer; Aravind Kokkirala; David M O'Sullivan; David I Silverman
Journal:  Cardiol Res       Date:  2011-11-20

8.  High T2-weighted signal intensity is associated with myocardial deformation in hypertrophic cardiomyopathy.

Authors:  Ruo-Yang Shi; Dong-Aolei An; Bing-Hua Chen; Rui Wu; Chong-Wen Wu; Liang Du; Jiong Zhu; Meng Jiang; Jian-Rong Xu; Lian-Ming Wu
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

9.  Myocardial structural alteration and systolic dysfunction in preclinical hypertrophic cardiomyopathy mutation carriers.

Authors:  Kai Hang Yiu; Douwe E Atsma; Victoria Delgado; Arnold C T Ng; Tomasz G Witkowski; See Hooi Ewe; Dominique Auger; Eduard R Holman; Anneke M van Mil; Martijn H Breuning; Hung Fat Tse; Jeroen J Bax; Martin J Schalij; Nina Ajmone Marsan
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

10.  Hypothesis and theory: mechanical instabilities and non-uniformities in hereditary sarcomere myopathies.

Authors:  Alf Månsson
Journal:  Front Physiol       Date:  2014-09-15       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.